Primary Insider Notification

15. Jun 2018 | 1 min read

Bård Sundrehagen, Chief Executive Officer in Gentian Diagnostics AS, has today sold 50,000 Shares in Gentian Diagnostics AS at a price of NOK 50 per share. Following the transaction, the total holding held by Bård Sundrehagen is 307,010 shares.

 

MeldingsID: 453767
UtstederID: GENT-ME
Instrument: GENT-ME
Marked: Merkur Market
Kategori: MELDEPLIKTIG HANDEL FOR PRIMÆRINNSIDERE
Informasjonspliktige opplysninger: Ja

Vedlegg: Primary insider notification Baard Sundrehagen (4)

You may also read


May 06, 2026 - Ole Sørlie

Gentian Diagnostics: First quarter 2026 report

Moss, 6 May 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests,..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics ASA terminates NT-proBNP assay development

Moss, 6 May 2026 Following a comprehensive review of performance data and market dynamics, Gentian..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics: Ex dividend NOK 0.60 today

Moss, 6 May 2026 The shares in Gentian Diagnostics ASA will be traded ex dividend NOK 0.60 as of today. The..